期刊文献+

Hzf and hCAS/CSEIL: making the right choice in p53-mediated tumour suppression 被引量:3

Hzf and hCAS/CSEIL: making the right choice in p53-mediated tumour suppression
下载PDF
导出
摘要 Preventing the propagation of damaged cells is a central component of tumour suppression. A key factor in this process is the transcription factor p53 - a fact exemplified by its frequent inactivation in human cancer. Since its discovery, over forty thousand reports have been published investigating p53 function and regulation. It is known that p53 mediates the expression of a diverse set of target genes which are broadly grouped by the biological response they provoke, with the best characterized being the induction of growth arrest, during which cellular damage is repaired, or the induction of apoptosis, which serves to eradicate damaged cells that may otherwise go on to form a tumour .
出处 《Cell Research》 SCIE CAS CSCD 2007年第10期829-831,共3页 细胞研究(英文版)
  • 相关文献

参考文献10

  • 1Crighton D, Ryan KM. Splicing DNA-damage responses to tumour cell death. Biochim Biophys Acta 2004; 1705:3-15.
  • 2Samuels-Lev Y, O'Connor D J, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001; 8:781-794.
  • 3Bergamaschi D, Samuels Y, O'Neil N J, et al. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 2003; 33:162-167.
  • 4Budhram-Mahadeo VS, Bowen S, Lee S, et al. Bm-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation ofbax expression. Nucleic Acids Res 2006; 34:6640-6652.
  • 5Coutts AS, La Thangue NB. The p53 response: emerging levels of co-factor complexity. Biochem Biophys Res Commun 2005; 331:778-785.
  • 6Das S, Raj L, Zhao B, et al. Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation. Cell 2007; 130:624-637.
  • 7Tanaka T, Ohkubo S, Tatsuno I, Prives C. hCAS/CSEIL Associates with Chromatin and Regulates Expression of Select p53 Target Genes. Cell 2007; 130:638-650.
  • 8Casolari JM, Brown CR, Komili S, West J, Hieronymus H, Silver PA. Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell 2004; 117:427-439.
  • 9Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator ofglycolysis and apoptosis. Cell 2006; 126:107-120.
  • 10Crighton D, Wilkinson S, O'Prey J, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121-134.

同被引文献15

  • 1Tang-Yi Tsao,Chin-Shaw Stella Tsai,Jai-Nien Tung,Shun-Liang Chen,Chia-Herng Yue,Ching-Fong Liao,Chi-Chao Wang,Ming-Chung Jiang.Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon[J]. Molecular and Cellular Biochemistry . 2009 (1-2)
  • 2Ian E. Krop,Eric P. Winer.Ten years of HER2-directed therapy: still questions after all these years[J]. Breast Cancer Research and Treatment . 2009 (2)
  • 3Shiraki K,Fujikawa K,Sugimoto K,et al.Cellular ap-optosis susceptibility protein and proliferation in humanhepatocellular carcinoma. International Journal of Molecular Medicine . 2006
  • 4Ginestier C,Cervera N,Finetti P,et al.Prognosis andgene expression profiling of 20q13-amplified breast canc-ers. Clinical Cancer Research . 2006
  • 5Tung MC,Tsai CS,Tung JN,et al.Higher Prevalenceof Secretory CSE1L/CAS in Sera of Patients with Meta-staticCancer. Cancer Epidemiology Biomarkers and Prevention . 2009
  • 6Stella Tsai CS,Chen HC,Tung JN,etal.Serum cellu-lar apoptosis susceptibility protein is a potential prog-nostic marker for metastatic colorectal cancer. American Journal of Pathology . 2010
  • 7Jiang MC,Liao CF.CSE1/CAS overexpression inhibits the tumorigenicity of HT-29colon cancer cells. Journal of Experimental and Clinical Cancer Research . 2004
  • 8CF Liao,SF Luo,TY Shen,CH Lin,JT Chien,SY Du,MC Jiang.CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB Rep . 2008
  • 9Wellmann A,Flemming P,Behrens P,et al.High expression of the proliferation and apoptosis associated CSE1L/CAS gene in hepatitis and liver neoplasms: correlation with tumor progression. International Journal of Molecular Medicine . 2001
  • 10Brinkmann,U,Gallo,M,Polymeropoulos,MH,Pastan,I.The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Research . 1996

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部